Forte Biosciences Ownership 2024 | Who Owns Forte Biosciences Now?
Institutional Ownership
41.33%
Insider Ownership
10.88%
Retail Ownership
47.79%
Institutional Holders
32.00
Forte Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 7.87% | 0.40% | 3,624,548 | - | - | 1,946,383 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 7.09% | 0.04% | 3,265,359 | - | - | 1,753,498 | Jun 30, 2024 |
| BVF INC/IL | 6.47% | 0.04% | 2,982,105 | - | - | 1,601,390 | Jun 30, 2024 |
| CABLE CAR CAPITAL LLC | 4.41% | 1.15% | 2,031,987 | - | - | 1,091,177 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 3.99% | 0.00% | 1,838,965 | - | - | 987,524 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 3.93% | 0.00% | 1,810,455 | - | - | 972,214 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 3.82% | 0.68% | 1,761,702 | - | - | 946,034 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.44% | - | 665,230 | - | - | 357,228 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75% | - | 346,292 | 2,860 | 0.83% | 186,008 | Jun 30, 2024 |
| BLACKROCK INC. | 0.38% | - | 174,858 | - | - | 93,899 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.35% | 0.02% | 159,258 | -11,252 | -6.60% | 85,522 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 133,400 | 1,300 | 0.98% | 71,636 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.09% | - | 40,811 | -53 | -0.13% | 21,916 | Jun 30, 2024 |
| STATE STREET CORP | 0.08% | - | 37,564 | -4,100 | -9.84% | 20,172,000 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.06% | - | 26,817 | -94 | -0.35% | 14,401,000 | Jun 30, 2024 |
| UBS GROUP AG | 0.05% | - | 24,310 | 24,277 | 73566.67% | 13,055 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 20,776 | 2 | 0.01% | 11,157 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 15,798 | 4,156 | 35.70% | 8,484 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.03% | - | 14,017 | -510 | -3.51% | 7,527,000 | Jun 30, 2024 |
| ARIES WEALTH MANAGEMENT | 0.03% | 0.00% | 13,000 | - | - | 6,981 | Jun 30, 2024 |
Forte Biosciences's largest institutional shareholder is TYBOURNE CAPITAL MANAGEMENT (HK) LTD, holding 7.87% of the company's total share outstanding, currently valued at $1.95M. The top 10 institutional shareholders own together 40.15% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CABLE CAR CAPITAL LLC | 4.41% | 1.15% | 2,031,987 | - | - | 1,091,177 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 3.82% | 0.68% | 1,761,702 | - | - | 946,034 | Jun 30, 2024 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 7.87% | 0.40% | 3,624,548 | - | - | 1,946,383 | Jun 30, 2024 |
| BVF INC/IL | 6.47% | 0.04% | 2,982,105 | - | - | 1,601,390 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 7.09% | 0.04% | 3,265,359 | - | - | 1,753,498 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.35% | 0.02% | 159,258 | -11,252 | -6.60% | 85,522 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 3.99% | 0.00% | 1,838,965 | - | - | 987,524 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 3.93% | 0.00% | 1,810,455 | - | - | 972,214 | Jun 30, 2024 |
| ARIES WEALTH MANAGEMENT | 0.03% | 0.00% | 13,000 | - | - | 6,981 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 15,798 | 4,156 | 35.70% | 8,484 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 133,400 | 1,300 | 0.98% | 71,636 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.09% | - | 40,811 | -53 | -0.13% | 21,916 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.03% | - | 14,017 | -510 | -3.51% | 7,527,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75% | - | 346,292 | 2,860 | 0.83% | 186,008 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.44% | - | 665,230 | - | - | 357,228 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.02% | - | 10,745 | - | - | 5,888 | Jun 30, 2024 |
| UBS GROUP AG | 0.05% | - | 24,310 | 24,277 | 73566.67% | 13,055 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.06% | - | 26,817 | -94 | -0.35% | 14,401,000 | Jun 30, 2024 |
| BLACKROCK INC. | 0.38% | - | 174,858 | - | - | 93,899 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 20,776 | 2 | 0.01% | 11,157 | Jun 30, 2024 |
The largest Forte Biosciences shareholder by % of total assets is CABLE CAR CAPITAL LLC. The company owns 2.03M shares of Forte Biosciences (FBRX), representing 1.15% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| UBS GROUP AG | 0.05% | - | 24,310 | 24,277 | 73566.67% | 13,055 | Jun 30, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.03% | 0.00% | 15,798 | 4,156 | 35.70% | 8,484 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.75% | - | 346,292 | 2,860 | 0.83% | 186,008 | Jun 30, 2024 |
| MORGAN STANLEY | 0.01% | - | 3,804 | 2,810 | 282.70% | 2,043 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.29% | 0.00% | 133,400 | 1,300 | 0.98% | 71,636 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.00% | - | 265 | 265 | 100.00% | 142 | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 128 | 128 | 100.00% | 69 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.05% | - | 20,776 | 2 | 0.01% | 11,157 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | - | - | 17 | - | - | 9 | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | 3 | - | - | 2 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 453 | - | - | 243 | Jun 30, 2024 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 0.00% | - | 193 | - | - | 112 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,080 | - | - | 582 | Jun 30, 2024 |
| BLACKROCK INC. | 0.38% | - | 174,858 | - | - | 93,899 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.02% | - | 10,745 | - | - | 5,888 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.44% | - | 665,230 | - | - | 357,228 | Jun 30, 2024 |
| ARIES WEALTH MANAGEMENT | 0.03% | 0.00% | 13,000 | - | - | 6,981 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 3.93% | 0.00% | 1,810,455 | - | - | 972,214 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 3.99% | 0.00% | 1,838,965 | - | - | 987,524 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 7.09% | 0.04% | 3,265,359 | - | - | 1,753,498 | Jun 30, 2024 |
As of Jun 30 2024, Forte Biosciences's largest institutional buyer is UBS GROUP AG. The company purchased 24.28K stocks of FBRX, valued at $13.05K.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.35% | 0.02% | 159,258 | -11,252 | -6.60% | 85,522 | Jun 30, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -11,122 | -100.00% | - | Jun 30, 2024 |
| STATE STREET CORP | 0.08% | - | 37,564 | -4,100 | -9.84% | 20,172,000 | Jun 30, 2024 |
| GROUP ONE TRADING, L.P. | 0.03% | - | 14,017 | -510 | -3.51% | 7,527,000 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -253 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.06% | - | 26,817 | -94 | -0.35% | 14,401,000 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.09% | - | 40,811 | -53 | -0.13% | 21,916 | Jun 30, 2024 |
| CABLE CAR CAPITAL LLC | 4.41% | 1.15% | 2,031,987 | - | - | 1,091,177 | Jun 30, 2024 |
| BML CAPITAL MANAGEMENT, LLC | 3.82% | 0.68% | 1,761,702 | - | - | 946,034 | Jun 30, 2024 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 7.87% | 0.40% | 3,624,548 | - | - | 1,946,383 | Jun 30, 2024 |
| BVF INC/IL | 6.47% | 0.04% | 2,982,105 | - | - | 1,601,390 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 7.09% | 0.04% | 3,265,359 | - | - | 1,753,498 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | 3.99% | 0.00% | 1,838,965 | - | - | 987,524 | Jun 30, 2024 |
| FARALLON CAPITAL MANAGEMENT LLC | 3.93% | 0.00% | 1,810,455 | - | - | 972,214 | Jun 30, 2024 |
| ARIES WEALTH MANAGEMENT | 0.03% | 0.00% | 13,000 | - | - | 6,981 | Jun 30, 2024 |
| VANGUARD GROUP INC | 1.44% | - | 665,230 | - | - | 357,228 | Jun 30, 2024 |
| HSBC HOLDINGS PLC | 0.02% | - | 10,745 | - | - | 5,888 | Jun 30, 2024 |
| BLACKROCK INC. | 0.38% | - | 174,858 | - | - | 93,899 | Jun 30, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | 0.00% | - | 1,080 | - | - | 582 | Jun 30, 2024 |
| LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | 0.00% | - | 193 | - | - | 112 | Jun 30, 2024 |
As of Jun 30 2024, Forte Biosciences's biggest institutional seller is ADAR1 CAPITAL MANAGEMENT, LLC. The company sold -11.25K shares of FBRX, valued at $85.52K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 0.00% | - | 128 | 128 | 100.00% | 69 | Jun 30, 2024 |
Forte Biosciences's largest new institutional shareholder by number of shares is FMR LLC, purchased 128.00 shares, valued at $69.00, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TWO SIGMA SECURITIES, LLC | - | - | - | -11,122 | -100.00% | - | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -253 | -100.00% | - | Jun 30, 2024 |
Forte Biosciences's largest sold out institutional shareholder by shares sold is TWO SIGMA SECURITIES, LLC, sold -11.12K shares, valued at -, as of undefined.
Forte Biosciences Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| ALGER FUNDS | 1.24% | 1,192,842 | - | - | Jan 31, 2024 |
| ALGER FUNDS II | 0.81% | 183,247 | - | - | Jan 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.47% | 122,577 | - | - | Jan 31, 2024 |
| ALGER PORTFOLIOS | 0.46% | 173,373 | - | - | Dec 31, 2023 |
| MERIDIAN FUND INC | 0.17% | 394,615 | - | - | Mar 28, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.04% | 123,807 | 4,595 | 3.85% | Feb 29, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.03% | 279,964 | - | - | Jan 31, 2024 |
| VANGUARD EXPLORER FUND | 0.02% | 278,390 | - | - | Jan 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.02% | 36,865 | - | - | Mar 28, 2024 |
| NEW COVENANT FUNDS | 0.01% | 61,361 | - | - | Dec 31, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.01% | 5,348 | - | - | Mar 31, 2024 |
| MASTER ADVANTAGE SMID CAP LLC | 0.01% | 1,259 | 1,259 | - | Dec 31, 2020 |
| ETFis Series Trust I | 0.00% | 5,233 | - | - | Jan 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.00% | 1,729 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.00% | 16,626 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 636,913 | -149,484 | -19.01% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 331 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 16,473 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 214,410 | 126,683 | 144.41% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 24,801 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 885 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 10,536 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 8,257 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 10,700 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 4,539 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 1,590 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 600 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 624 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 5,656 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 3,357 | - | - | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 204 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 22,266 | - | - | Jan 31, 2024 |
| Fidelity Rutland Square Trust II | 0.00% | 80,953 | - | - | Feb 29, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,427 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 5,792 | - | - | Mar 28, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 107 | - | - | Dec 31, 2023 |
| SUNAMERICA SERIES TRUST | 0.00% | 9,090 | - | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 26,472 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 2,113 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 241 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 1,332 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 38,331 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 1,659 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 69,417 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 2,004 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 59 | - | - | Dec 31, 2023 |
| VALIC Co I | 0.00% | 4,181 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 400 | - | - | Mar 28, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 13,637 | - | - | Mar 31, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 67 | - | - | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 11 | - | - | Dec 31, 2023 |
| AIM INVESTMENT FUNDS (INVESCO INVESTMENT FUNDS) | 0.00% | 133,563 | - | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 26,183 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,962 | - | - | Jan 31, 2024 |
| AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS) | 0.00% | 18,837 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 1,069 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 1,729 | - | - | Feb 29, 2024 |
| Blackstone Alternative Investment Funds | 0.00% | 800 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 1,629 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 17,909 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 4,572 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 457 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 9,700 | - | - | Mar 31, 2024 |
| ETF Series Solutions | 0.00% | 72 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 640 | - | - | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 4,216 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,006 | - | - | Dec 31, 2023 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 1,115 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 7,447 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 2 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 1,881 | - | - | Feb 29, 2024 |
| Bridge Builder Trust | 0.00% | 1,339 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 1,346 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 1,319 | - | - | Mar 28, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 15 | - | - | Jan 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 2,400 | - | - | Feb 29, 2024 |
Forte Biosciences's largest mutual fund holder by % of total assets is "ALGER FUNDS", owning 1.19M shares, compromising 1.24% of its total assets.
Forte Biosciences Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 32 | - |
| 31 Mar, 24 | 32 | -8.57% |
| 31 Dec, 23 | 35 | 9.38% |
| 30 Sep, 23 | 32 | 3.23% |
| 30 Jun, 23 | 31 | 3.33% |
| 31 Mar, 23 | 30 | -9.09% |
| 31 Dec, 22 | 33 | 26.92% |
| 30 Sep, 22 | 26 | -18.75% |
| 30 Jun, 22 | 32 | -31.91% |
| 31 Mar, 22 | 47 | -16.07% |
| 31 Dec, 21 | 56 | -21.13% |
| 30 Sep, 21 | 71 | -6.58% |
| 30 Jun, 21 | 76 | 22.58% |
| 31 Mar, 21 | 62 | 26.53% |
| 31 Dec, 20 | 49 | 2.08% |
| 30 Sep, 20 | 48 | 92.00% |
| 30 Jun, 20 | 25 | 2400.00% |
| 31 Mar, 20 | 1 | - |
| 31 Dec, 19 | 1 | - |
| 30 Sep, 19 | 1 | - |
| 30 Jun, 19 | 1 | - |
| 31 Mar, 19 | 1 | - |
As of 30 Jun 24, 32 institutions are holding Forte Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 19,046,381 | -0.01% |
| 31 Mar, 24 | 19,048,537 | 0.98% |
| 31 Dec, 23 | 18,863,225 | 12.96% |
| 30 Sep, 23 | 16,699,693 | 381.91% |
| 30 Jun, 23 | 3,465,339 | -10.35% |
| 31 Mar, 23 | 3,865,337 | 1.64% |
| 31 Dec, 22 | 3,802,982 | 42.40% |
| 30 Sep, 22 | 2,670,585 | 15.50% |
| 30 Jun, 22 | 2,312,254 | -40.66% |
| 31 Mar, 22 | 3,896,597 | -27.42% |
| 31 Dec, 21 | 5,368,794 | 38.46% |
| 30 Sep, 21 | 3,877,461 | -54.96% |
| 30 Jun, 21 | 8,609,580 | 8.05% |
| 31 Mar, 21 | 7,968,361 | -5.05% |
| 31 Dec, 20 | 8,392,583 | 23.35% |
| 30 Sep, 20 | 6,804,098 | 135.91% |
| 30 Jun, 20 | 2,884,150 | 4369824.24% |
| 31 Mar, 20 | 66 | - |
| 31 Dec, 19 | 66 | - |
| 30 Sep, 19 | 66 | - |
| 30 Jun, 19 | 66 | - |
| 31 Mar, 19 | 66 | - |
Forte Biosciences (FBRX) has 19.05M shares outstanding as of 30 Jun 24, down -0.01% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 41.33% | 1.14% |
| 31 Mar, 24 | 60.34% | 2.43% |
| 31 Dec, 23 | 49.82% | 0.79% |
| 30 Sep, 23 | 79.35% | 29.16% |
| 30 Jun, 23 | 16.50% | 4.87% |
| 31 Mar, 23 | 18.40% | 3.84% |
| 31 Dec, 22 | 21.88% | 10.99% |
| 30 Sep, 22 | 14.11% | 5.75% |
| 30 Jun, 22 | 15.66% | 2.25% |
| 31 Mar, 22 | 26.40% | 1.86% |
| 31 Dec, 21 | 37.70% | 5.09% |
| 30 Sep, 21 | 27.23% | 0.68% |
| 30 Jun, 21 | 63.29% | 1.75% |
| 31 Mar, 21 | 60.13% | 0.46% |
| 31 Dec, 20 | 114.05% | 1.33% |
| 30 Sep, 20 | 92.46% | 12.96% |
| 30 Jun, 20 | 26.71% | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | - |
As of 30 Jun 24, Forte Biosciences is held by 41.33% institutional shareholders, representing a 1.14% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 9 | 28.57% |
| 31 Mar, 24 | 7 | -30.00% |
| 31 Dec, 23 | 10 | -28.57% |
| 30 Sep, 23 | 14 | 27.27% |
| 30 Jun, 23 | 11 | 37.50% |
| 31 Mar, 23 | 8 | -33.33% |
| 31 Dec, 22 | 12 | 9.09% |
| 30 Sep, 22 | 11 | -15.38% |
| 30 Jun, 22 | 13 | -23.53% |
| 31 Mar, 22 | 17 | -39.29% |
| 31 Dec, 21 | 28 | -24.32% |
| 30 Sep, 21 | 37 | -31.48% |
| 30 Jun, 21 | 54 | 35.00% |
| 31 Mar, 21 | 40 | 17.65% |
| 31 Dec, 20 | 34 | -2.86% |
| 30 Sep, 20 | 35 | 45.83% |
| 30 Jun, 20 | 24 | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | -100.00% |
| 31 Mar, 19 | 1 | - |
9 institutional shareholders have increased their position in FBRX stock as of 30 Jun 24 compared to 7 in the previous quarter (a 28.57% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 6 | 20.00% |
| 31 Mar, 24 | 5 | - |
| 31 Dec, 23 | 5 | -28.57% |
| 30 Sep, 23 | 7 | -12.50% |
| 30 Jun, 23 | 8 | -11.11% |
| 31 Mar, 23 | 9 | -18.18% |
| 31 Dec, 22 | 11 | 10.00% |
| 30 Sep, 22 | 10 | -16.67% |
| 30 Jun, 22 | 12 | -42.86% |
| 31 Mar, 22 | 21 | 61.54% |
| 31 Dec, 21 | 13 | - |
| 30 Sep, 21 | 13 | -7.14% |
| 30 Jun, 21 | 14 | 7.69% |
| 31 Mar, 21 | 13 | 85.71% |
| 31 Dec, 20 | 7 | -36.36% |
| 30 Sep, 20 | 11 | - |
| 30 Jun, 20 | - | - |
| 31 Mar, 20 | - | - |
| 31 Dec, 19 | - | - |
| 30 Sep, 19 | - | - |
| 30 Jun, 19 | - | - |
| 31 Mar, 19 | - | - |
6 institutional shareholders have reduced their position in FBRX stock as of 30 Jun 24 compared to 5 in the previous quarter (a 20.00% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 32 | - | 19,046,381 | -0.01% | 41.33% | 1.14% | 9 | 28.57% | 6 | 20.00% |
| 31 Mar, 24 | 32 | -8.57% | 19,048,537 | 0.98% | 60.34% | 2.43% | 7 | -30.00% | 5 | - |
| 31 Dec, 23 | 35 | 9.38% | 18,863,225 | 12.96% | 49.82% | 0.79% | 10 | -28.57% | 5 | -28.57% |
| 30 Sep, 23 | 32 | 3.23% | 16,699,693 | 381.91% | 79.35% | 29.16% | 14 | 27.27% | 7 | -12.50% |
| 30 Jun, 23 | 31 | 3.33% | 3,465,339 | -10.35% | 16.50% | 4.87% | 11 | 37.50% | 8 | -11.11% |
| 31 Mar, 23 | 30 | -9.09% | 3,865,337 | 1.64% | 18.40% | 3.84% | 8 | -33.33% | 9 | -18.18% |
| 31 Dec, 22 | 33 | 26.92% | 3,802,982 | 42.40% | 21.88% | 10.99% | 12 | 9.09% | 11 | 10.00% |
| 30 Sep, 22 | 26 | -18.75% | 2,670,585 | 15.50% | 14.11% | 5.75% | 11 | -15.38% | 10 | -16.67% |
| 30 Jun, 22 | 32 | -31.91% | 2,312,254 | -40.66% | 15.66% | 2.25% | 13 | -23.53% | 12 | -42.86% |
| 31 Mar, 22 | 47 | -16.07% | 3,896,597 | -27.42% | 26.40% | 1.86% | 17 | -39.29% | 21 | 61.54% |
| 31 Dec, 21 | 56 | -21.13% | 5,368,794 | 38.46% | 37.70% | 5.09% | 28 | -24.32% | 13 | - |
| 30 Sep, 21 | 71 | -6.58% | 3,877,461 | -54.96% | 27.23% | 0.68% | 37 | -31.48% | 13 | -7.14% |
| 30 Jun, 21 | 76 | 22.58% | 8,609,580 | 8.05% | 63.29% | 1.75% | 54 | 35.00% | 14 | 7.69% |
| 31 Mar, 21 | 62 | 26.53% | 7,968,361 | -5.05% | 60.13% | 0.46% | 40 | 17.65% | 13 | 85.71% |
| 31 Dec, 20 | 49 | 2.08% | 8,392,583 | 23.35% | 114.05% | 1.33% | 34 | -2.86% | 7 | -36.36% |
| 30 Sep, 20 | 48 | 92.00% | 6,804,098 | 135.91% | 92.46% | 12.96% | 35 | 45.83% | 11 | - |
| 30 Jun, 20 | 25 | 2400.00% | 2,884,150 | 4369824.24% | 26.71% | - | 24 | - | - | - |
| 31 Mar, 20 | 1 | - | 66 | - | - | - | - | - | - | - |
| 31 Dec, 19 | 1 | - | 66 | - | - | - | - | - | - | - |
| 30 Sep, 19 | 1 | - | 66 | - | - | - | - | - | - | - |
| 30 Jun, 19 | 1 | - | 66 | - | - | - | - | -100.00% | - | - |
| 31 Mar, 19 | 1 | - | 66 | - | - | - | 1 | - | - | - |
Forte Biosciences Insider Shareholders Trades
Open Market Insider Trades
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Forte Biosciences's stock was made by Riley Antony A on Jul 03 2024, selling 3,345 shares at $0.55 per share (valued at $1.83K).
Forte Biosciences Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | 4 | 50.00% |
| Q2 2024 | 2 | 4 | 50.00% |
| Q1 2024 | 6 | 6 | 100.00% |
| Q4 2023 | 14 | 6 | 233.33% |
| Q3 2023 | 16 | 6 | 266.67% |
| Q2 2023 | 3 | 6 | 50.00% |
| Q1 2023 | 4 | - | - |
| Q4 2022 | 3 | - | - |
| Q2 2022 | 13 | 2 | 650.00% |
| Q1 2022 | 9 | - | - |
| Q3 2021 | - | 3 | - |
| Q2 2021 | 6 | - | - |
| Q1 2021 | 1 | 1 | 100.00% |
| Q2 2020 | 10 | 8 | 125.00% |
| Q1 2020 | 2 | - | - |
| Q4 2019 | 11 | - | - |
| Q2 2019 | 13 | - | - |
| Q1 2019 | 4 | - | - |
| Q4 2018 | 1 | - | - |
| Q2 2018 | 7 | - | - |
2 total buy trades, and 4 total sell trades (buy/sell ratio of 0.50%) were made by Forte Biosciences's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q4 2023 | 11 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 2 | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | 3 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q2 2020 | 4 | - | - |
| Q1 2020 | 1 | - | - |
| Q4 2019 | - | - | - |
| Q2 2019 | 6 | - | - |
| Q1 2019 | - | - | - |
| Q4 2018 | - | - | - |
| Q2 2018 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Forte Biosciences's stocks.
Forte Biosciences Peer Ownership
FBRX Ownership FAQ
Who Owns Forte Biosciences?
Forte Biosciences is owned by institutional shareholders (41.33%), insiders (10.88%), and public (47.79%). The largest institutional shareholder of Forte Biosciences is TYBOURNE CAPITAL MANAGEMENT (HK) LTD (7.87% of total shares) and the top mutual fund owner is ALGER FUNDS (1.24% of total shares).
Who are the major institutional shareholders of Forte Biosciences?
Forte Biosciences's major institutional shareholders are TYBOURNE CAPITAL MANAGEMENT (HK) LTD, PERCEPTIVE ADVISORS LLC, BVF INC/IL, CABLE CAR CAPITAL LLC, and FRED ALGER MANAGEMENT, LLC. The top five shareholders own together 29.82% of the company's share outstanding.
How many Forte Biosciences shareholders are there?
As of Jun 2024, there are 32 institutional shareholders of Forte Biosciences.
What percentage of Forte Biosciences is owned by TYBOURNE CAPITAL MANAGEMENT (HK) LTD?
TYBOURNE CAPITAL MANAGEMENT (HK) LTD owns 3.62M shares of Forte Biosciences, representing 7.87% of the company's total shares outstanding, valued at $1.95M (as of Jun 2024).
What percentage of Forte Biosciences is owned by PERCEPTIVE ADVISORS LLC?
As of Jun 2024, PERCEPTIVE ADVISORS LLC holds 3.27M shares of Forte Biosciences (FBRX), compromising 7.09% of the company, valued at $1.75M.
What percentage of Forte Biosciences is owned by BVF INC/IL?
BVF INC/IL is the third largest holder of Forte Biosciences. The company owns 2.98M of the company's shares outstanding (worth $1.6M).